substance p has been researched along with Hypertrophy, Right Ventricular in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MJ; Lai, YL | 1 |
| Chen, CF; Chen, LW; Lai, YL | 1 |
| Katzman, NJ; Lai, YL | 1 |
3 other study(ies) available for substance p and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Tachykinin dysfunction attenuates monocrotaline-induced pulmonary hypertension.
Topics: Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Organ Size; Rats; Rats, Wistar; Receptors, Tachykinin; RNA Interference; RNA, Double-Stranded; Substance P; Tachykinins | 2003 |
Chronic activation of neurokinin-1 receptor induces pulmonary hypertension in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atmospheric Pressure; Biphenyl Compounds; Blood Pressure; Cardiac Output; Female; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Neurokinin-1 Receptor Antagonists; Pulmonary Wedge Pressure; Rats; Rats, Wistar; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Substance P; Vascular Resistance | 1999 |
Capsaicin pre- and post-treatment on rat monocrotaline pneumotoxicity.
Topics: Animals; Capsaicin; Functional Residual Capacity; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Monocrotaline; Neprilysin; Neurokinin A; Organ Size; Rats; Rats, Sprague-Dawley; Substance P; Total Lung Capacity | 2000 |